8STS
Crystal Structure of HIV-1 Reverse Transcriptase (Y181C, V106A) varient in Complex with 5-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)-4-fluorophenoxy)-7-fluoro-2-naphthonitrile (JLJ636), a non-nucleoside inhibitor
Summary for 8STS
Entry DOI | 10.2210/pdb8sts/pdb |
Related | 8STP 8STQ 8STR |
Descriptor | Reverse transcriptase/ribonuclease H, p51 RT, 5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-7-fluoronaphthalene-2-carbonitrile, ... (5 entities in total) |
Functional Keywords | reverse transcriptase, antiviral, drug design, hiv-1, viral protein, hydrolase |
Biological source | Human immunodeficiency virus type 1 BH10 More |
Total number of polymer chains | 4 |
Total formula weight | 229026.96 |
Authors | Hollander, K.,Jorgensen, W.L.,Anderson, K.S. (deposition date: 2023-05-11, release date: 2023-11-29, Last modification date: 2023-12-13) |
Primary citation | Hollander, K.,Chan, A.H.,Frey, K.M.,Hunker, O.,Ippolito, J.A.,Spasov, K.A.,Yeh, Y.J.,Jorgensen, W.L.,Ho, Y.C.,Anderson, K.S. Exploring novel HIV-1 reverse transcriptase inhibitors with drug-resistant mutants: A double mutant surprise. Protein Sci., 32:e4814-e4814, 2023 Cited by PubMed: 37861472DOI: 10.1002/pro.4814 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.02 Å) |
Structure validation
Download full validation report